A Johns Hopkins team has developed a gene editing approach that could make the treatment of sickle cell disease shorter and less risky, relieving some of the burden on patients
Using DNA as a scaffold, engineers create synthetic nanomaterial that could pave the way for rapid and more accurate diagnostic testing from a single molecule